首页|凝血功能指标组合在肾细胞癌转移和复发中的价值

凝血功能指标组合在肾细胞癌转移和复发中的价值

扫码查看
目的 探讨凝血功能相关检测指标及其组合在肾细胞癌(renal cell carcinoma,RCC)患者转移和术后复发中的潜在价值.方法 收集2018年1月至2024年6月南京中医药大学附属南京中医院和南京大学医学院附属金陵医院泌尿外科住院的RCC转移和术后复发患者39例,另收集RCC未转移患者64例、肾血管平滑肌瘤/嗜酸细胞瘤患者15例及肾囊肿患者118例作为对照组,凝固法检测凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(Fib),免疫比浊法检测纤维蛋白(原)降解产物(FDP)、D-二聚体(DD),发色底物法检测抗凝血酶Ⅲ(AT3).采用Mann-Whitney U非参数检验方法比较RCC复发/转移患者和对照组患者间血浆凝血指标等水平差异,结合患者临床资料,采用多因素Logistic回归分析和ROC曲线分析不同凝血指标及其组合对RCC转移和术后复发患者的区分价值.结果 7种凝血指标在RCC转移/复发患者组与对照组间差异有统计学意义(P均<0.05).ROC曲线分析结果显示,7种凝血指标水平均可区分RCC转移/复发患者与对照,其中DD价值最高,其ROC曲线下面积(AUCROC)为0.913(95%CI:0.859~0.967).多因素Logistic回归分析结果显示,Fib、FDP、DD和AT3与RCC转移/复发相关.不同指标组合结合ROC曲线分析结果显示,Fib、FDP、DD和AT3四指标组合对于RCC转移/复发患者最具判别价值,AUCROC为0.920(95%CI:0.865~0.974).结论 Fib、DD、FDP和AT3变化与患者转移及术后复发密切相关,其中Fib、FDP、DD和AT3四指标组合具备作为RCC复发和转移监测评估指标潜能..
Clinical value of coagulation index combination for metastasis and postoperative recurrence of renal cell carcinoma
Objective To explore the potential value of coagulation indicators and their combinations for metastasis and postoperative recurrence in renal cell carcinoma(RCC)patients.Methods A total of 39 RCC patients with metastasis and postoperative recurrence were enrolled,and the controls groups included 64 RCC patients without metastasis,15 patients with renal vascular leiomyoma/oncocy-toma and 118 patients with renal cysts.All the patients were diagnosed and hospitalized in the Department of Urology of Nanjing Hospi-tal of Chinese Medicine affiliated with Nanjing University of Chinese Medicine and Jinling Hospital affiliated with Nanjing University School of Medicine from January 2018 to June 2024.The coagulation indicators in the blood samples were measured.The levels of plas-ma prothrombin time(PT),activated partial thromboplastin time(APTT),thrombin time(TT)and fibrinogen(Fib)were analyzed by clotting method.The levels of fibrinogen degradation products(FDP)and D-Dimer(DD)were analyzed by immunological turbidim-etry assay,and the levels of antithrombin Ⅲ(AT3)were analyzed by chromogenic substrate method,respectively.The differences of coagulation indicators between RCC patients with metastasis and postoperative recurrence and the controls were assessed by Mann-Whit-ney U test.The potential value of coagulation indicators and their combinations for predicating metastasis and postoperative recurrence in RCC patients was evaluated through Logistic regression and ROC curve analysis.Results The plasma levels of the seven coagulation indicators showed significant differences between the patients with RCC metastatic/recurrent and the controls(all with P<0.05).The results of ROC curve analysis showed that the plasma levels of all the 7 coagulation index could distinguish the metastatic/recurrent RCC patients from the controls,and the DD level showed the highest value with the AUCROC=0.913(95%CI:0.859 to 0.967).Multi-ple logistic regression analysis revealed that the plasma levels of Fib,FDP,DD,and AT3 were associated with RCC metastasis/recur-rence.Logistic regression analysis combined with ROC curve analysis revealed that the panel of Fib,FDP,DD and AT3 had the best performance for discriminating RCC metastasis/recurrence along with the AUCROC of 0.920(95%CI:0.865 to 0.974).Conclusion Alterations of the levels of plasma Fib,DD,FDP and AT3 may be closely related to postoperative recurrence and metastasis in RCC patients,and the panel of Fib,FDP,DD and AT3 has the potential to serve as the monitoring and evaluation indicators for RCC recur-rence and metastasis.

renal cell carcinomacoagulation indexmetastaticrecurrencepredictive indicators

牛冬梅、胡雪玲、宋佳希、张春妮、汪俊军、王成

展开 >

南京中医药大学附属南京中医院医学检验科,南京 210022

南京大学医学院附属金陵医院检验科,南京 210002

肾细胞癌 凝血指标 转移 复发 预测指标

2024

临床检验杂志
江苏省医学会

临床检验杂志

CSTPCD
影响因子:0.746
ISSN:1001-764X
年,卷(期):2024.42(12)